nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Actinomycosis, a sheep in wolves' clothes
|
Neijens, V. |
|
1996 |
15 |
1 |
p. 131-135 5 p. |
artikel |
2 |
Activity of anti-erbB-2 recombinant toxin OLX-209 on lung cancer cell lines in the absence of erbB-2 gene amplification
|
|
|
1996 |
15 |
1 |
p. 143- 1 p. |
artikel |
3 |
A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients
|
|
|
1996 |
15 |
1 |
p. 139- 1 p. |
artikel |
4 |
Allelic deletion mapping on chromosome 5 in human lung carcinomas
|
|
|
1996 |
15 |
1 |
p. 142-143 2 p. |
artikel |
5 |
Alpha-fetoprotein-producing adenocarcinoma of the lung
|
Yoshino, Ichiro |
|
1996 |
15 |
1 |
p. 125-130 6 p. |
artikel |
6 |
Altered cJun expression: An early event in human lung carcinogenesis
|
|
|
1996 |
15 |
1 |
p. 140- 1 p. |
artikel |
7 |
Aspects of the epidemiology of lung cancer in smokers and nonsmokers in the United States
|
Kabat, Geoffrey C. |
|
1996 |
15 |
1 |
p. 1-20 20 p. |
artikel |
8 |
Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: Their heterology in form and analogy in immuno-histochemical characteristics
|
|
|
1996 |
15 |
1 |
p. 146-147 2 p. |
artikel |
9 |
Bioavailability of 50- and 75-mg oral etoposide in lung cancer patients
|
|
|
1996 |
15 |
1 |
p. 155- 1 p. |
artikel |
10 |
Bronchioloalveolar carcinoma: Computed tomography findings
|
|
|
1996 |
15 |
1 |
p. 149- 1 p. |
artikel |
11 |
Bronchogenic carcinoma: Incidence of metastases to normal sized lymph nodes
|
|
|
1996 |
15 |
1 |
p. 147- 1 p. |
artikel |
12 |
Calendar
|
|
|
1996 |
15 |
1 |
p. 137-138 2 p. |
artikel |
13 |
Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: A randomised phase II study
|
|
|
1996 |
15 |
1 |
p. 152- 1 p. |
artikel |
14 |
Chromosomal 11 alterations in non-small-cell lung carcinomas in Hong Kong
|
Chan, Andrew S.K. |
|
1996 |
15 |
1 |
p. 51-65 15 p. |
artikel |
15 |
Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer
|
|
|
1996 |
15 |
1 |
p. 154-155 2 p. |
artikel |
16 |
Clinico-pathological features and survival of lung cancer patients in Paris, France
|
|
|
1996 |
15 |
1 |
p. 146- 1 p. |
artikel |
17 |
Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: Preliminary results of an ongoing phase I/II study
|
|
|
1996 |
15 |
1 |
p. 152-153 2 p. |
artikel |
18 |
Comparison of pleuropneumonectomy and limited surgery for lung cancer with pleural dissemination
|
|
|
1996 |
15 |
1 |
p. 151- 1 p. |
artikel |
19 |
Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines
|
|
|
1996 |
15 |
1 |
p. 152- 1 p. |
artikel |
20 |
CYFRA 21-1 determination in patients with non-small cell lung cancer: Clinical utility for the detection of recurrences
|
|
|
1996 |
15 |
1 |
p. 147- 1 p. |
artikel |
21 |
Cytokeratin tumor marker levels in bronchial washing in the diagnosis of lung cancer
|
|
|
1996 |
15 |
1 |
p. 148- 1 p. |
artikel |
22 |
Detection of disseminated lung cancer cells in lymph nodes: Impact on staging and prognosis
|
|
|
1996 |
15 |
1 |
p. 146- 1 p. |
artikel |
23 |
Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung
|
|
|
1996 |
15 |
1 |
p. 153- 1 p. |
artikel |
24 |
Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma: A study of the Lung Cancer Study Group of West Japan
|
|
|
1996 |
15 |
1 |
p. 152- 1 p. |
artikel |
25 |
Early phase II study of oral administration of etoposide for 21 consecutive days in patients with non-small-cell lung cancer
|
|
|
1996 |
15 |
1 |
p. 156- 1 p. |
artikel |
26 |
Editorial Board
|
|
|
1996 |
15 |
1 |
p. IFC- 1 p. |
artikel |
27 |
Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for stage III nonsmall cell lung cancer
|
|
|
1996 |
15 |
1 |
p. 157- 1 p. |
artikel |
28 |
Etoposide and doxorubicin antagonize the in vitro activity of paclitaxel in human non-small cell lung cancer cell lines
|
Viallet, J. |
|
1996 |
15 |
1 |
p. 93-101 9 p. |
artikel |
29 |
Evaluation of the optimal duration of chemotherapy in phase II trials for inoperable non-small-cell lung cancer (NSCLC)
|
|
|
1996 |
15 |
1 |
p. 153-154 2 p. |
artikel |
30 |
Excellent survival in a subgroup of patients with intrapulmonary metastasis of lung cancer
|
|
|
1996 |
15 |
1 |
p. 150- 1 p. |
artikel |
31 |
Expression of bcl-2 — protein in small cell lung cancer
|
Kaiser, U. |
|
1996 |
15 |
1 |
p. 31-40 10 p. |
artikel |
32 |
Expression of IGF-1, TGF-α and p53 protein in imprint smears of bronchial biopsy specimens of lung cancer
|
|
|
1996 |
15 |
1 |
p. 145- 1 p. |
artikel |
33 |
Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer
|
|
|
1996 |
15 |
1 |
p. 155-156 2 p. |
artikel |
34 |
Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients
|
|
|
1996 |
15 |
1 |
p. 140- 1 p. |
artikel |
35 |
Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: Towards a paraneoplastic immune marker
|
|
|
1996 |
15 |
1 |
p. 144-145 2 p. |
artikel |
36 |
Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer
|
|
|
1996 |
15 |
1 |
p. 148-149 2 p. |
artikel |
37 |
Frequency and prognostic evaluation of 3p21–22 allelic losses in non-small-cell lung cancer
|
|
|
1996 |
15 |
1 |
p. 144- 1 p. |
artikel |
38 |
Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: Evidence for a new tumor suppressor gene on the short arm of chromosome 12
|
|
|
1996 |
15 |
1 |
p. 145- 1 p. |
artikel |
39 |
Gemcitabine: Clinical and economic impact in inoperable non-small cell lung cancer
|
|
|
1996 |
15 |
1 |
p. 153- 1 p. |
artikel |
40 |
Gingival metastasis of large-cell lung cancer that produced G-CSF
|
|
|
1996 |
15 |
1 |
p. 147- 1 p. |
artikel |
41 |
Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines
|
|
|
1996 |
15 |
1 |
p. 142- 1 p. |
artikel |
42 |
High plasma level of plasmin-α2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer
|
|
|
1996 |
15 |
1 |
p. 150- 1 p. |
artikel |
43 |
Hilar lymphnode metastasis of bronchogenic carcinoma; evaluation with ultrafast incremental dynamic CT (IDCT)
|
|
|
1996 |
15 |
1 |
p. 149- 1 p. |
artikel |
44 |
Histologic changes in small cell lung carcinoma after treatment
|
|
|
1996 |
15 |
1 |
p. 145- 1 p. |
artikel |
45 |
Hyperfractionated radiotherapy and concomitant cisplatin in Stage III non-small cell lung cancer: a Phase II study by the AIRO-Lombardia Cooperative Group
|
Palazzi, Mauro |
|
1996 |
15 |
1 |
p. 85-91 7 p. |
artikel |
46 |
IASLC annoucement
|
|
|
1996 |
15 |
1 |
p. 159- 1 p. |
artikel |
47 |
Immunohistochemical analysis of p53 mutations in bronchioalveolar carcinoma and conventional pulmonary adenocarcinoma
|
|
|
1996 |
15 |
1 |
p. 145-146 2 p. |
artikel |
48 |
Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: Improvement of tumour uptake by internalisation
|
|
|
1996 |
15 |
1 |
p. 144- 1 p. |
artikel |
49 |
Intraoperative brachytherapy using gelfoam radioactive plaque implants for resected stage III non-small cell lung cancer with positive margin: A pilot study
|
|
|
1996 |
15 |
1 |
p. 156- 1 p. |
artikel |
50 |
Isolation of a polyamine transport deficient cell line from the human non-small cell lung carcinoma line NCI H157
|
|
|
1996 |
15 |
1 |
p. 141-142 2 p. |
artikel |
51 |
KM195 as an immunohistochemical marker of adenocarcinoma of the lung
|
Kawai, Toshiaki |
|
1996 |
15 |
1 |
p. 41-50 10 p. |
artikel |
52 |
Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?
|
|
|
1996 |
15 |
1 |
p. 157- 1 p. |
artikel |
53 |
Long-term survival of patients with lung cancer from a defined geographical area before and after radiological screening
|
Hillerdal, Gunnar |
|
1996 |
15 |
1 |
p. 21-30 10 p. |
artikel |
54 |
Loss of heterozygosity at 9p21 loci and mutations of the MTS1 and MTS2 genes in human lung cancers
|
|
|
1996 |
15 |
1 |
p. 141- 1 p. |
artikel |
55 |
Lung cancer and solitary brain metastasis: Results of the combined surgical treatment
|
|
|
1996 |
15 |
1 |
p. 151-152 2 p. |
artikel |
56 |
Lung cancer in women: Selected topics in epidemiology and prevention
|
|
|
1996 |
15 |
1 |
p. 139- 1 p. |
artikel |
57 |
Lymphoid monoclonal antibodies reactive with lung tumors: Diagnostic applications
|
|
|
1996 |
15 |
1 |
p. 147- 1 p. |
artikel |
58 |
New design of N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) lung imaging in the patient with lung cancer
|
|
|
1996 |
15 |
1 |
p. 147-148 2 p. |
artikel |
59 |
N1 of lung cancer evaluated by thin-section dynamic CT
|
|
|
1996 |
15 |
1 |
p. 149- 1 p. |
artikel |
60 |
Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma
|
|
|
1996 |
15 |
1 |
p. 149- 1 p. |
artikel |
61 |
Paclitaxel plus hydroxyurea as second line therapy for non-small cell lung cancer
|
Stewart, David J. |
|
1996 |
15 |
1 |
p. 115-123 9 p. |
artikel |
62 |
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised Phase II trial
|
Comella, Pasquale |
|
1996 |
15 |
1 |
p. 103-114 12 p. |
artikel |
63 |
Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer
|
|
|
1996 |
15 |
1 |
p. 154- 1 p. |
artikel |
64 |
P53 in squamous metaplasia: A marker for risk of respiratory tract carcinoma
|
|
|
1996 |
15 |
1 |
p. 140- 1 p. |
artikel |
65 |
p53 protein accumulation and the presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlate with poor prognosis
|
|
|
1996 |
15 |
1 |
p. 144- 1 p. |
artikel |
66 |
p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: Relation to prognosis
|
|
|
1996 |
15 |
1 |
p. 143- 1 p. |
artikel |
67 |
Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation
|
Takigawa, Nagio |
|
1996 |
15 |
1 |
p. 67-77 11 p. |
artikel |
68 |
Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer
|
|
|
1996 |
15 |
1 |
p. 143-144 2 p. |
artikel |
69 |
Prognostic value of carcino-embryonic antigen in lung carcinoma before treatment
|
|
|
1996 |
15 |
1 |
p. 148- 1 p. |
artikel |
70 |
Pulmonary dust retention in silicotics with and without lung cancer
|
|
|
1996 |
15 |
1 |
p. 139- 1 p. |
artikel |
71 |
Putrescine accumulation in human pulmonary tumours
|
|
|
1996 |
15 |
1 |
p. 142- 1 p. |
artikel |
72 |
Radiolocalization of squamous lung carcinoma with 131I-labeled epidermal growth factor
|
|
|
1996 |
15 |
1 |
p. 143- 1 p. |
artikel |
73 |
Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis
|
|
|
1996 |
15 |
1 |
p. 155- 1 p. |
artikel |
74 |
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: A North Central Cancer Treatment Group study
|
|
|
1996 |
15 |
1 |
p. 154- 1 p. |
artikel |
75 |
Ras oncoproteins in human plasma from lung cancer patients and healthy controls
|
|
|
1996 |
15 |
1 |
p. 142- 1 p. |
artikel |
76 |
Recent data on cancer due to asbestos in Germany
|
|
|
1996 |
15 |
1 |
p. 140-141 2 p. |
artikel |
77 |
Resection rates and postoperative mortality in 7,899 patients with lung cancer
|
|
|
1996 |
15 |
1 |
p. 151- 1 p. |
artikel |
78 |
Results of repeated lung resection for homolateral recurrence of lung cancer after conservative resection
|
|
|
1996 |
15 |
1 |
p. 151- 1 p. |
artikel |
79 |
Sequential molecular genetic changes in lung cancer development
|
|
|
1996 |
15 |
1 |
p. 142- 1 p. |
artikel |
80 |
Single agent activity of rhizoxin in non-small-cell lung cancer: A phase II trial of the EORTC early clinical trials group
|
|
|
1996 |
15 |
1 |
p. 155- 1 p. |
artikel |
81 |
Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography
|
|
|
1996 |
15 |
1 |
p. 150- 1 p. |
artikel |
82 |
Survival following resection for lung cancer as a second primary cancer
|
|
|
1996 |
15 |
1 |
p. 150-151 2 p. |
artikel |
83 |
Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial
|
|
|
1996 |
15 |
1 |
p. 149- 1 p. |
artikel |
84 |
The accuracy of CT-based inhomogeneity corrections and in vivo dosimetry for the treatment of lung cancer
|
|
|
1996 |
15 |
1 |
p. 156-157 2 p. |
artikel |
85 |
The changes of the stromal elastotic framework in the growth of peripheral lung adenocarcinomas
|
|
|
1996 |
15 |
1 |
p. 146- 1 p. |
artikel |
86 |
The changing epidemiology of smoking and lung cancer histology
|
|
|
1996 |
15 |
1 |
p. 141- 1 p. |
artikel |
87 |
The clinical significance of serum soluble interleukin-2 receptors in lung cancer
|
Yano, Tokujiro |
|
1996 |
15 |
1 |
p. 79-84 6 p. |
artikel |
88 |
The effect of tobacco on lung cancer risk depends on CYP2D6 activity
|
|
|
1996 |
15 |
1 |
p. 139-140 2 p. |
artikel |
89 |
The tendency of lung cancer crude mortality rate in Ecuador. A comparative analysis with other malignant neoplasias during the decade 1984–1993
|
|
|
1996 |
15 |
1 |
p. 140- 1 p. |
artikel |
90 |
Thymopentin treatment in patients undergoing surgery for lung carcinoma: Analysis of actuarial survival
|
|
|
1996 |
15 |
1 |
p. 150- 1 p. |
artikel |
91 |
Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking
|
|
|
1996 |
15 |
1 |
p. 141- 1 p. |
artikel |
92 |
Two cases of lung cancer with leptomeningeal metastasis diagnosed by gadolinium enhanced MRI
|
|
|
1996 |
15 |
1 |
p. 148- 1 p. |
artikel |
93 |
Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: A randomized Study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
|
|
|
1996 |
15 |
1 |
p. 154- 1 p. |
artikel |
94 |
Unsuspected lung cancer found in work-up for lung reduction operation
|
|
|
1996 |
15 |
1 |
p. 151- 1 p. |
artikel |